We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Settings

Save and close

JAX Frontend Platform

NOD.CB17-Prkdcscid/J strain an ideal model for cancer and autoimmune disease

JAX Notes | October 1, 2004

The NOD.CB17-Prkdcscid/J strain (Stock Number 001303; formerly NOD/LtSz-Prkdcscid/J), a congenic JAX® GEMM® strain, is an ideal model for cancer and autoimmune disease. The strain is homozygous for a mutation in the catalytic subunit of a DNA-activated protein kinase (Prkdc) gene mutation, which arose spontaneously in a colony of BALB/c-Ighb (C.B-17) mice at the Institute for Cancer Research in Philadelphia. Because mice of this strain are defective in their ability to both repair double-stranded DNA damage and properly rearrange genes that code for antigen-specific receptors on lymphocytes, they have severe combined immune deficiency, the reason they are called scid mice. Homozygous scid mice have no functional T and B cells, have lymphopenia, hypogammaglobulinemia, and a normal hematopoietic microenvironment.

The thymus, lymph nodes, and splenic follicles of scid mice are virtually devoid of lymphocytes, and the functions of their antigen-presenting, myeloid, and natural killer (NK) cells are dependent on the strain backgrounds, which include C57BL/6J, BALB/cByJ, C3H/HeSnJSmn, and NOD/LtSz. Most scid homozygotes have no detectable IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA. Some scid mice spontaneously develop partial immune reactivity. Those with serum Ig levels greater than 1 µ5g/ml are considered "leaky." Leakiness increases with age, is higher in mice housed under non-specific pathogen free conditions, and is generally high on the C57BL/6J and BALB/cByJ backgrounds, low on the C3H/HeSnJSmn background, and even lower on the NOD/LtSz background.

JAX® Mice strain NOD.CB17-Prkdcscid/J (001303)

JAX® Mice strain NOD.CB17-Prkdcscid/J (Stock No. 001303)

  • Splenic engraftment of human CEM T-lymphoblastoid cells are four-fold greater than in the C.B-17/Sz-Prkdcscid mice.
  • NK cell activity is considerably less than in C.B-17/Sz-Prkdcscid mice.
  • Their macrophage populations are functionally less mature than those of C.B-17/Sz-Prkdcscid mice.
  • Whereas both they and NOD/LtSz +/+ control mice lack hemolytic complement activity, the serum hemolytic complement activity of C.B-17/Sz-scid and C57BL/6Sz-scid mice is higher than that in their wildtype controls.
  • Age-dependent increases in serum Ig levels (> 1 B5g/ml) were observed in only 2 of 30 NOD/LtSz-scid mice vs. 21 of 29 C.B-17/Sz-scid mice.

Because they accept allogeneic and xenogeneic grafts (respectively, grafts from the same and different species), NOD.CB17-Prkdcscid/J mice are ideal models for cell transfer experiments, such as those involving reconstitution of human hematopoietic cells; they have successfully accepted a variety of normal and malignant human cell and tissue transplants. Additionally, they may be useful for delineating the role of T cell subsets in autoimmune diabetes and as a source for insulitis-free islets. NOD.CB17-Prkdcscid/J mice are both insulitis- and diabetes-free throughout life and serve as lymphocyte-deficient and diabetes-free controls for NOD/LtJ mice (Stock Number001976). However, they have a high incidence of thymic lymphomas, limiting their mean lifespan to 8.5 months under SPF conditions.

©2025 The Jackson Laboratory